The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

Global Pen Needles Market OverviewThe global pen needles market is projected to grow at a robust CAGR of 9% over the next five years. This growth is primarily driven by the rising prevalence of ...

It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already ...

FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

Dr. Lynn Kramer, chief clinical officer at Eisai, which developed one of the medications, Leqembi, spearheaded a program to transfer the IV infusions into an auto-injector pen that patients can use ...

US FDA grants priority review status to Pfizer’s Hympavzi sBLA to treat two haemophilia A or B patient populations with significant medical need: New York Monday, February 9, 20 ...

Pfizer Inc. (NYSE: PFE)today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company's ...

The family of a five-year-old boy who died from a severe allergic reaction at school said they were one step forward in ...

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company's supplemental Biologics License Application (sBLA) for HYMPAVZI® ...

Q4 2025 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsGiuseppe Di Salvo - VP of Investor Relations ...

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings ...